Company / Total Assets
Pfizer Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$208.2B
FY2025
5-year range
$181.5B / $226.5B
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#1 of 214
Health Care
What the data says
Among 214 Health Care companies, Pfizer is in the top 0% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $154.2B in FY2020 to $226.5B in FY2023.
Based on SEC 10-K filings.
$208.2B in FY2025 with a 5-year CAGR of +6.2%. Ranks 1st among 214 companies in Health Care.
Declined from $226.5B to $208.2B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +1.8%
- 5-Year CAGR
- +6.2%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 214This company $208.2B Sector average $7.5B
▼
+2686.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.2%, indicating consistent growth.
- In FY2025, total assets decreased 2.5% year-over-year.
- Ranks #1 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $208.2B | -2.5% |
| FY2024 | $213.4B | -5.8% |
| FY2023 | $226.5B | +14.9% |
| FY2022 | $197.2B | +8.7% |
| FY2021 | $181.5B | +17.7% |
| FY2020 | $154.2B | -8.0% |
| FY2019 | $167.6B | +5.1% |
| FY2018 | $159.4B | -7.2% |
| FY2017 | $171.8B | +0.1% |
| FY2016 | $171.6B | +2.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026